Standout Papers

Improved Assessment of Significant Activation in Functional Magnetic Resonan... 1988 2026 2000 2013 2.9k
  1. Improved Assessment of Significant Activation in Functional Magnetic Resonance Imaging (fMRI): Use of a Cluster‐Size Threshold (1995)
    Steven D. Forman, Jonathan D. Cohen et al. Magnetic Resonance in Medicine
  2. Positron emission tomographic studies of the cortical anatomy of single-word processing (1988)
    Steven E. Petersen, Peter T. Fox et al. Nature
  3. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (2005)
    Randy L. Buckner, Abraham Z. Snyder et al. Journal of Neuroscience
  4. Nonoxidative Glucose Consumption During Focal Physiologic Neural Activity (1988)
    Peter T. Fox, Marcus E. Raichle et al. Science
  5. BRAIN WORK AND BRAIN IMAGING (2006)
    Marcus E. Raichle, Mark A. Mintun Annual Review of Neuroscience
  6. The default mode network and self-referential processes in depression (2009)
    Yvette I. Sheline, Deanna M. Barch et al. Proceedings of the National Academy of Sciences
  7. Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression (1999)
    Yvette I. Sheline, Mark A. Mintun et al. Journal of Neuroscience
  8. Positron Emission Tomographic Studies of the Processing of Singe Words (1989)
    Steven E. Petersen, Peter T. Fox et al. Journal of Cognitive Neuroscience
  9. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans (2005)
    Anne M. Fagan, Mark A. Mintun et al. Annals of Neurology
  10. Spatial working memory in humans as revealed by PET (1993)
    John Jonides, Edward E. Smith et al. Nature
  11. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study (2001)
    Yvette I. Sheline, Deanna M. Barch et al. Biological Psychiatry
  12. Donanemab in Early Alzheimer’s Disease (2021)
    Mark A. Mintun, Albert Lo et al. New England Journal of Medicine
  13. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus (2010)
    Yvette I. Sheline, Joseph L. Price et al. Proceedings of the National Academy of Sciences
  14. [ 11 C]PIB in a nondemented population (2006)
    Mark A. Mintun, Gina LaRossa et al. Neurology
  15. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography (1984)
    Mark A. Mintun, Marcus E. Raichle et al. Annals of Neurology
  16. Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults (2007)
    Anne M. Fagan, Catherine M. Roe et al. Archives of Neurology
  17. APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging (2009)
    John C. Morris, Catherine M. Roe et al. Annals of Neurology
  18. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET (2014)
    William E. Klunk, Robert A. Koeppe et al. Alzheimer s & Dementia
  19. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (2012)
    Christopher M. Clark, Michael J. Pontecorvo et al. The Lancet Neurology
  20. Amyloid deposition, hypometabolism, and longitudinal cognitive decline (2012)
    Susan Landau, Mark A. Mintun et al. Annals of Neurology
  21. Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease (2022)
    Michael J. Pontecorvo, Ming Lu et al. JAMA Neurology
  22. Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease (2025)
    Jennifer A. Zimmer, Paul Ardayfio et al. JAMA Neurology

Immediate Impact

3 by Nobel laureates 93 from Science/Nature 259 standout
Sub-graph 1 of 17

Citing Papers

High performance plasma amyloid-β biomarkers for Alzheimer’s disease
2018 StandoutNatureNobel
The road to restoring neural circuits for the treatment of Alzheimer's disease
2016 StandoutNature
40 intermediate papers

Works of Mark A. Mintun being referenced

APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
2009 Standout
Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
2005 Standout
and 25 more

Author Peers

Author Last Decade Papers Cites
Mark A. Mintun 12057 12193 9276 19859 276 42.0k
Marilyn Albert 8058 12800 9236 17043 213 35.7k
Reisa A. Sperling 17932 18779 5548 15463 527 39.5k
Robert A. Koeppe 8236 7709 4592 12919 376 33.6k
Eric M. Reiman 14635 11445 4291 10128 451 33.2k
Bruno Dubois 14581 18239 3318 12297 409 37.8k
Sandra Weıntraub 11465 18106 3153 16787 296 38.0k
William W. Seeley 8131 6919 3813 12790 268 26.2k
Joseph L. Price 6678 8091 3334 19656 175 41.3k
William J. Jagust 27333 31635 10235 19881 475 59.4k
Nancy C. Andreasen 3435 28611 9596 22047 502 55.7k

All Works

Loading papers...

Rankless by CCL
2026